Navigation Links
Center for Celiac Disease Opens

The Children’s Hospital of Philadelphia announces the establishment of the Center for Celiac Disease, a multidisciplinary resource created to diagnose//, treat and provide support for patients and families with celiac disease.

“A person with celiac disease is unable to digest gluten, a common ingredient found in many foods including bread, pasta and even condiments,” said Ritu Verma, M.D., gastroenterologist and director of the Center for Celiac Disease at Children’s Hospital. “This inability to digest gluten damages the lining of the small intestine and prevents the body from absorbing essential nutrients. The only treatment for celiac disease is a strict gluten-free diet.”

One of the challenges of celiac disease is that though it is relatively common, affecting approximately one in 133 people, the warning signs like small stature, fatigue and stomach irritation are relatively vague and may mimic other disorders like inflammatory bowel disease or lactose intolerance, making it difficult to diagnose. In some cases symptoms may be so mild that they are overlooked entirely. If celiac disease is not diagnosed, patients may face problems with osteoporosis, internal organ disorders and internal bleeding.

“The average patient lives with celiac disease for 11 years before being properly diagnosed,” said Dr. Verma. “The goal of the Center for Celiac Disease at Children’s Hospital is for families to get the answers they need and receive a comprehensive treatment plan and support that will last a lifetime.”

The Center for Celiac Disease consists of a comprehensive team of specialists including physicians, nutritionists, nurses, educators, laboratory technicians and clinical researchers, who provide individualized nutrition counseling and care for each patient.

“Celiac disease not only affects the child diagnosed with the disease, but also the entire family because treatment requires a drastic change in lifestyle and
'"/>




Page: 1 2

Related medicine news :

1. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
2. Osaka Medical Center study showed 70% of smokers couldn’t qui
3. Kalam To Lay Foundation Of Vellore Research Center
4. Free Treatment Center Established In Chennai
5. Analyzing Client-Centered Therapy.
6. Human Milk Center Caters To Premature Babies
7. Walk-In Health Centers Launched By The NHS For Commuters
8. Free HIV Tests Brings Crowd to the Testing Centers
9. Kerala To Become Testing Center For US Bound Nurses
10. Himachal Pradesh Fails To Become Health Tourism Center
11. Vanderbilt-Ingram Cancer Center To Study Ways To Prevent Chemo Brain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Center for Celiac Disease Opens

(Date:10/7/2008)...recommendations reflect previously published ACSM/... /PRNewswire-USNewswire/ -- Guidelines,for physica...f Health and,Human Services (HHS) were met with su... (ACSM) and the American Heart Association (AHA). ...l activity recommendations,last year, attended tod...
(Date:10/7/2008)...NGTON, Oct. 7 /PRNewswire-USNewswire/ -- Kristi Ya...ner of Dancing With the Stars, has been,named chai...istmas Seals,Campaign in an effort to help raise f...prevent lung disease and promote lung health., Th...ion began in 1907,to conquer Tuberculosis. Today, ...
(Date:10/7/2008)...ly to feel distress, more likely to enjoy better q... Oct. 7 (HealthDay News) -- End-of-life discussion... not result in more distress for patients. In fact...ions and enhanced quality of life in a patient,s f... past two decades, the debate has been around when...
(Date:10/7/2008)...se announcement of planned bequest comes at stem c...re-USNewswire/ -- Just over one year,ago, retail p...ift to the,University of Michigan, to endow a new ...g and preventing human disease., Today, at the in...uncing that he will bequeath an additional $22 mil...
Breaking Medicine News(10 mins):Health News:ACSM, AHA Support Federal Physical Activity Guidelines 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Alfred Taubman Announces New $22M Gift to U-M 2
...certain chemicals has been known to be associated ...etc. from time immemorial. But it is known not unt...eased // following occupational exposure to minera...matiod factor remains unestablished. However, a nu...
...w kind of rat that will help them to study the eff... women that can lead to hypertension and heart fai... of Medicine // have created a better research rat...olved in hypertension. These rats will allow them ...
...iversity in New York are under investigation for a...esearch studies and filing false information on pr...th (NIH) to maintain government funding for a univ...cher at the pediatric center accused the center’s ...
...logical levels free radicals and antioxidants in d...ell established following our improved understandi...ential scope because of the fact that confirmation...that treatment for such disorders can be made very...
Other Medicine News:Health News:Protection against Alzheimer’s could be as simple as drinking green te 2
(Date:10/7/2008)...ss., Oct. 7 /- Taligen Therapeutics I...f the Company,s pipeline,candidates were presented...Basel, Switzerland. The data highlighted the candi...ment-mediated diseases., "These highlighted prese...ented at the conference, reveal the deep expertise...
(Date:10/7/2008)...pective Randomized Placebo-Controlled Phase II Stu...ed Overall Survival., MOUNTAIN VIEW, California, ...s now evaluated the mature Phase II data from the,...TVAC(TM) that had been,obtained as part of the rec... Institute (NCI) in the US., The results from the...
(Date:10/7/2008)...nded to Eight On-Demand Tests for Use on the GeneX...UNNYVALE, Calif., Oct. 7 /-...e of Xpert(TM) vanA/vanB as a European CE,IVD Mark...Diagnostic,Medical Devices. The test delivers rapi...ost commonly associated with vancomycin-resistant,...
(Date:10/6/2008)...J., Oct. 6 /- Pharmasset, I...mith, Ph.D., is joining the,Company as Vice Presid...ions. Dr. Smith will be responsible for all invest... Chief Financial Officer Kurt,Leutzinger., Most r... Biotechnology,Analyst at JPMorgan Securities, and...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 2Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 3MIT study suggests caution on new anti obesity drug in kids 18717 1MIT study suggests caution on new anti obesity drug in kids 18717 2Patients with chronic illness benefit from telehealth intervention 18715 1Patients with chronic illness benefit from telehealth intervention 18715 2
...ESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasda...the scalable production, survival following engraf...nfarcted rats was presented,today for GRNCM1, the ...herapeutic for heart failure, at the International...ting in Cairns,Australia., The presentation was o...
...ne 19, 2007 /PRNewswire-FirstCall/ --,Genaera Corp...ter,on trodusquemine (MSI-1436), its novel anti-ob...iation (ADA) 67th Scientific,Sessions, June 22 to ..., "Trodusquemine is a Multiple,Pathway Inhibitor t...sity, and Improves Plasma Insulin and Leptin Level...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: